HeartSciences (HSCSW) Change in Account Payables (2021 - 2026)
HeartSciences' (HSCSW) quarterly Change in Account Payables came in at -$92400.0 in Q2 2026, down 6.93% on a YoY basis from -$99275.7 in Q2 2025, and down 370.45% quarter-over-quarter from $34165.0 in Q4 2025.
Analysis
HeartSciences (HSCSW) Change in Account Payables (2021 - 2026) Analysis & Trends
HeartSciences (HSCSW) has reported Change in Account Payables for 6 consecutive years, with -$92400.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables fell 6.93% year-over-year to -$92400.0; the trailing twelve-month figure through Apr 2026 stood at -$180086.0 (down 39.04% YoY), and the FY2026 full-year result was -$334.0, up 99.74% from the prior year.
- Change in Account Payables declined to -$92400.0 in Q2 2026 per HSCSW's latest filing, from $34165.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $633457.0 in Q4 2023 and bottomed at -$673221.0 in Q1 2024.
- Historically, Change in Account Payables has averaged -$5888.4 across 5 years, with a median of -$35436.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 970.47% in 2023, then slumped 374.31% in 2024.
- Over 5 years, Change in Account Payables stood at $339522.0 in 2022, then soared by 86.57% to $633457.0 in 2023, then sank by 118.89% to -$119658.0 in 2024, then soared by 128.55% to $34165.0 in 2025, then tumbled by 370.45% to -$92400.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$92400.0, $34165.0, and -$35436.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn | -200.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 1.39 Mn |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn | 698,000.00 |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn | 1.26 Mn |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - | -11.30 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | -15.40 Mn |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn | -930,000.00 |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - | -92,400.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -92,400.00 |
| Oct 31, 2025 | 34,165.00 |
| Jul 31, 2025 | -35,436.00 |
| Apr 30, 2025 | -86,415.00 |
| Jan 31, 2025 | 128,228.00 |
| Oct 31, 2024 | -119,658.00 |
| Jul 31, 2024 | -51,677.00 |
| Apr 30, 2024 | 33,107.00 |
| Jan 31, 2024 | -673,221.00 |
| Oct 31, 2023 | 633,457.00 |
| Jul 31, 2023 | -176,529.00 |
| Apr 30, 2023 | -389,318.00 |
| Jan 31, 2023 | 245,421.00 |
| Oct 31, 2022 | 339,522.00 |
| Jul 31, 2022 | -157,801.00 |
| Apr 30, 2022 | 296,646.00 |
| Jan 31, 2022 | -28,194.00 |
| Oct 31, 2021 | 167,025.00 |
| Jul 31, 2021 | -76,513.00 |